Elicio Therapeutics ELTX Growth Metrics (2020-2026)

NASDAQ ELTX
$1.62 +0.04 (+2.87%)
As of: Oct 21, 2026 · 1:18 PM EDT
Reported Financials

Elicio Therapeutics Quarterly Growth Metrics

Periods 25 quarters
Latest Jun 2026

Elicio Therapeutics reported asset growth of 6.10% for the quarter ended Jun 2026. These growth metrics cover 25 quarters of results from Jun 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Growth MetricsGrowth Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Growth Ratios
Assets Growth (1y)
103.84%-41.63%-43.51%-44.23%-76.52%-48.60%-46.88%-49.46%19.78%-41.39%-58.13%23.88%3.80%14.97%87.48%-26.32%-8.22%-19.38%6.10%
Assets Growth (3y)
-16.92%-43.97%-49.91%-29.58%-33.66%-29.77%-25.29%-22.73%4.50%-18.41%-5.92%
Assets Growth (5y)
-11.39%-30.43%-24.22%
Assets (QoQ)
-12.30%-12.21%-15.81%-12.85%-13.41%-63.04%84.29%-9.93%-17.63%-12.40%-9.82%-35.66%143.73%-26.60%-0.12%4.92%-4.21%-8.56%-12.27%38.08%
Capital Expenditures Growth (1y)Capex Growth (1y)
6,000.00%260.00%129.10%163.89%-99.28%950.00%-64.44%
Capital Expenditures Growth (3y)Capex Growth (3y)
-5.27%-26.32%255.69%-44.37%7.72%-44.78%
Capital Expenditures Growth (5y)Capex Growth (5y)
9.86%
Capital Expenditures (QoQ)Capex (QoQ)
-75.00%-40.98%-82.11%-76.47%1,025.00%
Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y)
156.47%-44.06%-99.49%-98.21%-93.06%-88.26%3,525.75%707.01%109.45%38.28%-84.20%75.30%36.64%54.82%544.91%-20.78%5.36%-18.54%6.39%
Cash & Equivalents Growth (3y)Cash & Equiv. Growth (3y)
-28.04%-55.05%-69.21%-36.73%-41.67%-36.89%233.03%123.79%44.47%20.37%2.72%
Cash & Equivalents Growth (5y)Cash & Equiv. Growth (5y)
-11.71%-35.17%-27.50%
Cash & Equivalents (QoQ)Cash & Equiv. (QoQ)
-12.43%-13.61%-17.75%-99.18%207.53%234.75%39.25%152.94%-31.55%-13.12%-8.07%-71.10%659.59%-32.28%4.16%20.36%-6.69%-9.94%-19.47%57.21%
Cash from Investing Activities Growth (1y)Cash from Investing Growth (1y)
-6,000.00%-260.00%-129.10%-163.89%105.37%117.65%-240.00%64.44%
Cash from Investing Activities Growth (3y)Cash from Investing Growth (3y)
5.27%71.00%-255.69%27.51%44.37%-7.72%44.78%
Cash from Investing Activities Growth (5y)Cash from Investing Growth (5y)
-9.86%
Cash from Investing Activities (QoQ)Cash from Investing (QoQ)
75.00%40.98%82.11%276.47%-250.00%-1,500.00%
Cash from Operations Growth (1y)Cash from Ops. Growth (1y)
30.73%-169.75%-24.72%158.27%64.56%49.34%48.00%-254.42%3.73%-36.00%-48.94%5.77%-40.29%11.63%16.52%-0.25%-52.41%22.27%-15.08%8.77%
Cash from Operations Growth (3y)Cash from Ops. Growth (3y)
2.32%9.55%38.18%-35.37%1.15%5.36%21.78%15.25%13.53%-51.23%-27.20%2.24%-12.68%4.84%
Cash from Operations Growth (5y)Cash from Ops. Growth (5y)
-2.99%6.91%12.76%-18.43%1.49%4.96%
Cash from Operations (QoQ)Cash from Ops. (QoQ)
-44.33%5.51%-8.99%139.20%-187.78%-35.09%-11.86%-16.41%45.28%-90.84%-22.51%26.35%18.53%-20.21%-15.73%11.55%-23.87%38.69%-71.33%29.88%
EBITDA Margin Growth (1y)
0.01M0.20M0.40M0.24M-1.87M
EBITDA Margin Growth (3y)
-1.74M-0.32M-1.04M-0.19M
EBITDA Margin (QoQ)
0.23M0.11M-0.09M-0.01M1.53M-0.80M0.56M
EBIT Growth (1y)
-36.02%205.66%27.35%65.84%63.38%-140.73%46.12%-24.79%-86.67%-57.56%-31.21%-40.47%3.96%-43.48%-4.83%7.63%22.23%34.39%1.25%-3.35%
EBIT Growth (3y)
14.69%23.35%2.40%12.14%19.92%15.71%13.09%-42.95%9.50%-17.43%-11.72%-14.05%-10.75%-10.27%
EBIT Growth (5y)
3.10%10.19%7.03%8.58%11.87%10.58%
EBIT Margin Growth (1y)
0.03M0.31M0.45M0.24M-1.90M
EBIT Margin Growth (3y)
-1.76M-0.30M-0.95M-0.15M
EBIT Margin (QoQ)
0.23M0.11M-0.09M-0.01M1.56M-0.81M0.57M
EBIT (QoQ)
13.63%192.87%-198.98%56.98%7.41%-3.31%-30.93%0.36%-38.50%12.80%-9.04%-6.67%5.31%-30.28%20.33%6.01%20.28%-9.91%-19.90%1.63%
EBT Growth (1y)
-36.02%205.66%27.35%59.99%56.54%-141.36%43.76%-15.80%-53.71%-55.20%-26.14%-28.21%2.19%-45.94%-4.14%6.64%19.66%33.05%-1.40%-5.77%
EBT Growth (3y)
13.46%21.19%3.14%12.14%19.82%15.94%13.23%-43.21%9.60%-11.50%-6.50%-14.89%-10.03%-8.18%
EBT Growth (5y)
3.16%10.14%6.51%7.90%11.46%10.12%
EBT Margin Growth (1y)
0.03M0.31M0.45M0.23M-2.06M
EBT Margin Growth (3y)
-1.93M-0.29M-0.95M-0.15M
EBT Margin (QoQ)
0.23M0.11M-0.09M-0.02M1.74M-0.82M0.57M
EBT (QoQ)
13.63%192.87%-198.98%49.61%6.18%11.61%-34.59%-3.74%-24.54%10.75%-9.40%-5.44%4.98%-33.16%21.94%5.47%18.24%-10.96%-18.23%1.39%
EPS (Basic) Growth (1y)
55.76%126.95%84.94%57.68%54.60%-142.00%-13.14%-0.10%46.77%20.06%56.82%73.72%-9.00%35.16%24.81%-2.66%56.45%56.08%24.99%35.07%
EPS (Basic) Growth (3y)
33.68%44.18%52.54%55.11%58.10%51.89%35.89%-30.41%28.39%35.36%36.78%38.94%37.56%44.05%
EPS (Basic) Growth (5y)
37.59%45.76%44.91%51.89%47.09%40.56%
EPS (Basic) (QoQ)
8.50%200.14%-144.70%-3.33%1.84%7.38%-20.42%8.57%47.80%-39.10%34.96%44.35%-116.51%17.26%24.58%24.02%8.15%16.56%-28.80%34.23%
EPS (Diluted) Growth (1y)
55.76%126.95%84.94%57.68%54.60%-142.00%-13.14%-0.10%46.77%20.06%56.82%73.72%-9.00%35.16%24.81%-2.66%56.45%56.08%24.99%35.07%
EPS (Diluted) Growth (3y)
33.68%44.18%52.54%55.11%58.10%51.89%35.89%-30.41%28.39%35.36%36.78%38.94%37.56%44.05%
EPS (Diluted) Growth (5y)
37.59%45.76%44.91%51.89%47.09%40.56%
EPS (Diluted) (QoQ)
8.50%200.14%-144.70%-3.33%1.84%7.38%-20.42%8.57%47.80%-39.10%34.96%44.35%-116.51%17.26%24.58%24.02%8.15%16.56%-28.80%34.23%
FCF Margin Growth (1y)
0.16M-0.45M0.24M0.28M-2.52M
FCF Margin Growth (3y)
-2.25M0.05M-1.77M-0.47M
FCF Margin (QoQ)
0.10M0.10M-0.09M0.18M2.22M-1.11M0.51M
Free Cash Flow Growth (1y)FCF Growth (1y)
30.46%-169.96%-24.31%151.76%64.71%48.81%47.89%-269.97%2.90%-34.24%-48.63%5.37%-39.08%11.18%16.52%0.22%-52.41%22.48%-15.08%8.77%
Free Cash Flow Growth (3y)FCF Growth (3y)
2.33%9.56%38.00%-35.37%1.26%5.93%21.88%15.17%13.53%-53.33%-27.20%2.59%-12.60%4.85%
Free Cash Flow Growth (5y)FCF Growth (5y)
-2.94%6.93%12.76%-18.44%1.55%5.40%
Free Cash Flow (QoQ)FCF (QoQ)
-41.62%5.65%-8.72%135.63%-196.58%-36.85%-10.65%-16.22%44.83%-89.20%-22.51%26.00%18.91%-20.83%-15.13%11.55%-23.87%38.54%-70.92%29.88%
Gross Margin Growth (1y)
0.00M0.00M
Gross Margin (QoQ)
0.00-167.00
Gross Profit Growth (1y)
204.80%7,560.06%
Gross Profit (QoQ)
170.37%1,647.12%
Interest Coverage Ratio Growth (1y)Interest Cover Growth (1y)
-86.49%-201,132.89%-7,147.64%-1,146.50%-1,946.78%99.30%98.77%78.56%76.67%74.99%54.44%57.30%51.10%
Interest Coverage Ratio Growth (3y)Interest Cover Growth (3y)
-107.28%-52.24%26.02%-4.51%-32.67%
Interest Coverage Ratio (QoQ)Interest Cover (QoQ)
8.36%-1,110.53%64.78%52.27%-98,787.67%56.40%93.94%21.63%66.13%23.73%-5.92%14.73%63.69%-38.93%0.72%2.35%
Net Cash Flow Growth (1y)NCF Growth (1y)
-257.01%-167.33%-116.34%152.00%123.30%127.19%112.03%76.47%-252.37%-176.06%-158.12%-171.72%554.16%-195.85%119.09%134.46%-106.45%77.22%-1,831.10%179.85%
Net Cash Flow Growth (3y)NCF Growth (3y)
33.72%41.71%-36.75%-28.85%-26.23%13.02%53.44%15.11%26.27%-24.17%-34.74%-35.95%-57.68%-11.57%
Net Cash Flow Growth (5y)NCF Growth (5y)
15.36%-6.80%-16.69%-15.93%-15.30%21.38%
Net Cash Flow (QoQ)NCF (QoQ)
-10.72%3.89%-11.96%143.65%-50.38%12.14%-50.49%540.50%-142.84%44.02%62.16%-690.32%371.32%-136.47%102.44%1,326.79%-150.77%-28.80%-85.54%330.65%
Net Income Growth (1y)
11.12%151.57%80.76%57.25%54.16%-144.67%-13.73%-3.56%-48.07%-34.55%-47.30%4.37%-76.75%-56.49%5.23%-46.09%46.48%44.89%-5.48%22.19%
Net Income Growth (3y)
15.32%28.11%15.51%32.33%31.43%24.91%-6.25%-43.27%-16.66%-13.10%-11.89%-5.08%-13.77%-2.82%
Net Income Growth (5y)
3.25%12.29%10.61%23.19%20.27%13.61%
Net Income (QoQ)
8.01%194.82%-147.41%-3.39%1.38%7.60%-20.72%5.85%-41.00%16.03%-32.16%38.88%-160.59%25.66%19.96%5.78%4.53%23.46%-53.19%30.50%
Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y)
11.12%151.57%80.76%57.25%54.16%-144.67%-13.73%-3.56%-48.07%-34.55%-47.30%4.37%-76.75%-56.49%5.23%-46.09%46.48%44.89%-5.48%22.19%
Net Income towards Common Stockholders Growth (3y)Net Income Growth (3y)
15.32%28.11%15.51%32.33%31.43%24.91%-6.25%-43.27%-16.66%-13.10%-11.89%-5.08%-13.77%-2.82%
Net Income towards Common Stockholders Growth (5y)Net Income Growth (5y)
3.25%12.29%10.61%23.19%20.27%13.61%
Net Income towards Common Stockholders (QoQ)Net Income (QoQ)
8.01%194.82%-147.41%-3.39%1.38%7.60%-20.72%5.85%-41.00%16.03%-32.16%38.88%-160.59%25.66%19.96%5.78%4.53%23.46%-53.19%30.50%
Net Margin Growth (1y)
0.11M0.63M0.95M0.20M-1.83M
Net Margin Growth (3y)
-1.66M-0.22M-0.56M0.20M
Net Margin (QoQ)
0.21M0.11M-0.05M-0.07M1.50M-0.76M0.40M
Operating Income Growth (1y)Op. Inc Growth (1y)
-36.02%205.66%27.35%65.84%63.38%-140.73%46.12%-24.79%-86.67%-57.56%-31.21%-40.47%3.96%-43.48%-4.83%7.63%22.23%34.39%1.25%-3.35%
Operating Income Growth (3y)Op. Inc Growth (3y)
14.69%23.35%2.40%12.14%19.92%15.71%13.09%-42.95%9.50%-17.43%-11.72%-14.05%-10.75%-10.27%
Operating Income Growth (5y)Op. Inc Growth (5y)
3.10%10.19%7.03%8.58%11.87%10.58%
Operating Income (QoQ)Op. Inc (QoQ)
13.63%192.87%-198.98%56.98%7.41%-3.31%-30.93%0.36%-38.50%12.80%-9.04%-6.67%5.31%-30.28%20.33%6.01%20.28%-9.91%-19.90%1.63%
Operating Margin Growth (1y)
0.03M0.31M0.45M0.24M-1.90M
Operating Margin Growth (3y)
-1.76M-0.30M-0.95M-0.15M
Operating Margin (QoQ)
0.23M0.11M-0.09M-0.01M1.56M-0.81M0.57M
Profit After Tax Growth (1y)PAT Growth (1y)
-36.02%205.66%27.35%59.99%56.54%-141.36%43.76%-15.80%-53.71%-55.20%-26.14%-28.21%2.19%-45.94%-4.14%6.64%19.66%33.05%-1.40%-5.77%
Profit After Tax Growth (3y)PAT Growth (3y)
13.46%21.19%3.14%12.14%19.82%15.94%13.23%-43.21%9.60%-11.50%-6.50%-14.89%-10.03%-8.18%
Profit After Tax Growth (5y)PAT Growth (5y)
3.16%10.14%6.51%7.90%11.46%10.12%
Profit After Tax (QoQ)PAT (QoQ)
13.63%192.87%-198.98%49.61%6.18%11.61%-34.59%-3.74%-24.54%10.75%-9.40%-5.44%4.98%-33.16%21.94%5.47%18.24%-10.96%-18.23%1.39%
Property, Plant & Equipment (Net) Growth (1y)PP&E (Net) Growth (1y)
189.10%70.33%-5.83%-36.00%154.32%136.86%153.95%-37.49%-35.04%-32.25%-32.64%-32.28%-36.85%-37.28%-38.92%-42.09%-43.50%
Property, Plant & Equipment (Net) Growth (3y)PP&E (Net) Growth (3y)
66.26%37.18%13.16%3.26%2.31%0.87%-0.95%2.57%-36.41%-38.57%
Property, Plant & Equipment (Net) Growth (5y)PP&E (Net) Growth (5y)
13.59%0.24%-12.36%
Property, Plant & Equipment (Net) (QoQ)PP&E (Net) (QoQ)
15.29%-5.05%-7.10%-7.40%-21.65%277.30%-16.00%-7.12%-11.44%-5.98%-12.40%-7.65%-10.97%-12.33%-13.00%-10.06%-15.59%-14.46%
Return on Assets [ROA] Growth (1y)ROA Growth (1y)
0.00M0.00M0.00M0.00M0.00M0.00M-0.01M0.00M-0.01M-0.01M-0.01M-992.000.00M0.00M267.00-580.00346.000.00M
Return on Assets [ROA] Growth (3y)ROA Growth (3y)
-0.01M-0.02M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M
Return on Assets [ROA] Growth (5y)ROA Growth (5y)
-0.01M-0.01M
Return on Assets [ROA] (QoQ)ROA (QoQ)
-953.000.00M-1.00796.00894.00-0.01M-539.000.00M0.00M0.00M0.00M-0.01M0.01M0.00M0.00M628.00738.00671.000.00M0.00M
Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y)
0.00M0.00M0.00M0.00M0.00M-0.01M-0.01M-0.01M-0.01M-0.02M-0.01M0.00M-0.01M0.01M0.00M785.000.01M0.00M
Return on Capital Employed [ROCE] Growth (3y)ROCE Growth (3y)
-0.01M-0.03M-0.02M-0.02M-0.02M-0.02M-0.02M-0.01M-0.01M-0.01M
Return on Capital Employed [ROCE] Growth (5y)ROCE Growth (5y)
-0.01M-0.02M
Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ)
0.00M0.00M-37.000.00M0.00M-0.01M702.0027.00-0.01M0.00M-713.00-0.01M0.01M0.00M-0.01M0.00M0.00M-975.000.00M752.00
Return on Equity [ROE] Growth (1y)ROE Growth (1y)
0.17M-0.04M
Return on Equity [ROE] Growth (3y)ROE Growth (3y)
0.58M-0.25M
Return on Equity [ROE] Growth (5y)ROE Growth (5y)
-3.23M-0.11M
Return on Equity [ROE] (QoQ)ROE (QoQ)
0.00M-0.01M-0.02M-0.21M-0.07M0.01M-3.72M3.74M
Return on Sales [ROS] Growth (1y)ROS Growth (1y)
0.03M0.31M0.45M0.24M0.10M-0.15M-0.31M-1.90M-0.43M-1.11M-0.29M
Return on Sales [ROS] Growth (3y)ROS Growth (3y)
-0.25M-1.76M-0.30M-0.95M-0.15M
Return on Sales [ROS] (QoQ)ROS (QoQ)
0.23M0.11M-0.09M-0.01M0.09M-0.14M-0.25M-1.60M1.56M-0.81M0.57M
Revenue Growth (1y)
76.54%5,551.63%344.20%20.93%-94.03%
Revenue Growth (3y)
-62.32%-33.25%-45.33%-26.06%
Revenue (QoQ)
170.37%1,676.78%-93.65%-60.38%530.77%-69.51%100.00%
Share-based Compensation Growth (1y)Stock Comp. Growth (1y)
34.23%74.01%-99.39%-91.21%-94.96%-90.16%622.58%16.74%208.18%69.35%44.64%25.45%-7.37%37.69%59.57%102.86%122.29%66.38%67.89%31.69%
Share-based Compensation Growth (3y)Stock Comp. Growth (3y)
-35.43%-36.60%-40.72%-33.81%-60.14%-49.50%-47.61%-38.78%155.49%43.75%85.13%57.13%57.07%49.65%
Share-based Compensation Growth (5y)Stock Comp. Growth (5y)
-9.08%-8.30%-15.57%-7.85%-29.87%-19.22%
Share-based Compensation (QoQ)Stock Comp. (QoQ)
-19.65%-7.42%-98.47%670.97%-53.97%80.91%12.56%24.55%21.51%-0.59%-3.86%8.02%-10.29%47.77%11.42%37.33%-1.69%10.60%12.44%7.72%
Total Debt Growth (1y)
-53.04%2.12%
Total Debt Growth (5y)
-28.91%60.31%
Total Debt (QoQ)
4.10%-3.22%0.72%0.63%

Elicio Therapeutics Growth Metrics API

Pull Elicio Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=ELTX&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY